| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Problems & Why They Don't Get Solved |
|
Digg It - Problems & Why They Don't Get Solved
It is possible to find about 2,050,000,000 “problems” on the internet. Often, problems do no According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product t get solved because they do not have an owner. They saunter around like orphans that are not ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in taken care of. This could be the case when a problem is too big to address for a single own lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. er. Today, a local newspaper reviewed the situation about the shrinking of the Greenland Glac here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe iers. It is a problem that might cause a disaster in the end, but which (impact) is nearly in d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro visible at the moment. It is a standard long-term versus short-term issue where the former is ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc not often favored. Until there is no real need, no action will be undertaken. Besides that, easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi not everybody could be convinced that the melting will indeed cause a problem. Problems that nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically do get attention are those where the urgency is high. The Internet site of a company that go and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ es down for example. The production process could delay because of a part that was not delive ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ed (and previously purchased) by the purchase department. Or a constant jam in the traffic to ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a your call center because of a lack of agents (the problem of giving stress to your agents). dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod For this last issue the owner of the problem is the manager of the call center. Although... cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin There are available agents in the team next door, owned by another manager. The call overflow tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen could be routed to this neighboring team (call center), but the problem will be shifted; to t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel another team and to another moment in time. It is not sexy to talk about problems. You shoul ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d rather focus on a challenge. Either way, something needs to get solved. And that is no prob y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products lem; It is possible to find 3,230,000,000 “Solutions” on the Internet. And that is another . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de reason why problems do not always get an owner. It is much more interesting to own a solution elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip . There are too many of them, the question is, do they solve "your" problem? © 2006 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Machiavelli: The Prince - Lessons in Organizational Structure Ten Courses Of Study If You Want To Be Your Own Boss
|